Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
623.00
0.00
(0.00%)
As of February 28 at 1:17:08 PM CST. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,004,000
-3,004,000
-3,118,000
4,981,000
13,620,000
Investing Cash Flow
1,949,000
1,949,000
4,206,000
-5,176,000
-8,523,000
Financing Cash Flow
56,000
56,000
-1,377,000
-3,448,000
-873,000
End Cash Position
1,929,000
1,929,000
2,928,000
3,217,000
6,860,000
Income Tax Paid Supplemental Data
197,000
197,000
--
2,729,000
480,000
Interest Paid Supplemental Data
24,000
24,000
39,000
25,000
14,000
Capital Expenditure
-1,051,000
-1,051,000
-707,000
-400,000
-284,000
Issuance of Capital Stock
66,000
66,000
46,000
65,000
124,000
Repayment of Debt
--
--
--
--
-140,000
Repurchase of Capital Stock
--
--
-1,153,000
-3,329,000
-857,000
Free Cash Flow
-4,055,000
-4,055,000
-3,825,000
4,581,000
13,336,000
12/31/2021 - 4/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATOS.MX Atossa Therapeutics, Inc.
16.00
0.00%
INO.MX Inovio Pharmaceuticals, Inc.
40.00
0.00%
A89.MU Adocia SAS A
5.11
+9.30%
OCGN.MX Ocugen, Inc.
13.35
0.00%
NVV1.DU Novavax Inc
7.96
+16.74%
NVV1.F Novavax, Inc.
8.09
+0.65%
CRMD CorMedix Inc.
10.14
-2.12%
VERU Veru Inc.
0.5193
-0.08%
MRSN Mersana Therapeutics, Inc.
0.4885
-6.67%
ATOS Atossa Therapeutics, Inc.
0.7478
-2.34%